Salinomycin Induces apoptosis via death receptor-5 up-regulation in cisplatin-resistant ovarian cancer cells

Anticancer Research

Volumn 33, Issue 4, 2013, Pages 1457-1462

  Parajuli, Bidur ^a   Shin, So Jin ^a   Kwon, Sang Hoon ^a   Cha, Soon Do ^a   Chung, Rosa ^a   Park, Won Jin ^a   Lee, Hyun Gyo ^a   Cho, Chi Heum ^a  

^a Keimyung University School of Medicine   (South Korea)

Author keywords

A2780cis cells; Apoptosis; DR4; DR5; Ovarian cancer; Salinomycin

Indexed keywords

CASPASE 8; CISPLATIN; DEATH RECEPTOR 5; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SALINOMYCIN; TETRAZOLIUM;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANNEXIN A5; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL CYCLE; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOBLOTTING; OVARIAN NEOPLASMS; PYRANS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84876762664     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Agarwal R and Kaye SB: Ovarian cancer: Strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 3: 502-516, 2003. (Pubitemid 37328838)
2. Gupta PB, Onder TT, Jiang G, Kuper Wasser C, Weinberg RA and Lander ES: Identification of selective inhibitors of cancer stem cells by highthroughput screening. Cell 138: 645-659, 2009.
3. Miyazaki Y, Shibuya M, Sugawara H, Kawaguchi O and Hirsoe C: Salinomycin, a new polyether antibiotic. J Antibiot 27: 814-821, 1974.
4. Mahmoudi N, De Julian-Ortiz J V, Ciceron L, Galvez J, Mazier D, Danis M, Derouin F and Garcia-Domench F: Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening. J Antimicrob Chemother 57: 489-497, 2006. (Pubitemid 43240202)
5. Naujokat C, Fuch D and Opelz G: Salinomycin in cancer: A new mission for an old agent. Mol Med Report 3: 555-559, 2010.
6. Mitani M, Yamanishi T and Miyazaki Y: Salinomycin: A new monovalent cation ionophore. Biochem Biophys Res Commun 27: 1231-1236, 1975.
7. Fuchs D, Heinold A, OPelz G, Daniel V and Naujokat C: Salinomicin induces apoptosis and overcomes apoptosis resistance in human cancer cells. Biochem Biophys Res Commun 390: 734-749, 2009.
8. Zhang Y, Zhang H, Wang X, Wang J, Zhang X and Zhang Q: The eradication of breast cancer and cancer stem cells using octreotide-modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials 33: 679-691, 2012.
9. Lu D, Choi MY, Yu J, Castro JE, Kipps TJ and Carson DA: Salinomycin inhibits WNT signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc Natl Acad Sci USA 108: 13253-13257, 2011.
10. 2 arrest. Invest New Drugs 30: 1311-1318, 2013.
11. Riccioni R, Dupuis ML, Bernabei M, Petrucci E, Pasquini L, Mariani G, Cianfriglia M and Testa U: The cancer stem cell selective inhibitor salinomycin is a P-glycoprotein inhibitor. Blood Cells Mol Dis 45: 86-92, 2010.
12. Srivastava RK: TRAIL/APO 2L: mechanisms and clinical applications in cancer. Neoplasia 3: 535-46, 2001. (Pubitemid 33151020)
13. Shankar S, Chen X and Srivastava RK: Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo. Prostate 62: 165-86, 2005. (Pubitemid 40096782)
14. Zhang B, Wang X, Cai F, Chen W, Loesch U, Bitzer J and Zhong XY: Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK. Tumor Biol 33: 1855-1862, 2012.
15. Martin SJ and Green DR: Apoptosis and cancer: The failure of controls on cell death and cell survival. Crit Rev Oncol Hematol 18: 137-53, 1995.
16. Degterev D and Yuan J: Expansion and evolution of cell death program. Nat Rev Mol Cell Biol 9: 378-390, 2008. (Pubitemid 351574200)
17. Fuchs D, Daniel V, Sadeghi M, Oopelz G and Naujokat C: Salinomcin induces apoptosis and overcomes ABC transportermediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 394: 1098-1104, 2010.
18. Boehmerlen W and Endres M: Salinomycin induces calpain and cytochrome c-mediated neuronal cell death. Cell Death 2: 168, 2011.
19. + cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol 18: 1797-1804, 2011.
20. Kim KY, Yu SN, Lee SY, Chun SS, Choi YL, Park YM, Song CS, Chatterjee B and Ahn SC: Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem Biophys Res Commun 413: 80-86, 2011.
21. Chen G and Goeddle DV: TNF, TNF-R1 signaling: A beautiful pathway. Science 296: 1634-1635, 2002. (Pubitemid 34579145)
22. Fumarola C, Zerbini A and Guidotti GG: Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis. Cell Death Differ 8: 1004-13, 2001. (Pubitemid 32994651)
23. Qiao L, StuderE, Leach K, Mckinstry R, Gupta S, Decker R, Kukreja R, Valerie K, Nagarkatti P, EI Deiry W, Molkentin J, Schmidt-Ullrich R, Fisher PB, Grant S, Hylemon PB and Dent P: Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: Inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol Biol Cell 12: 2609-2645, 2001.